Age-related differences in kidney injury biomarkers induced by cisplatin

作者: Yu Jin Shin , Tae Hyung Kim , A Jin Won , Ja Young Jung , Seung Jun Kwack

DOI: 10.1016/J.ETAP.2014.03.014

关键词:

摘要: Acute kidney injury (AKI) occurs in a half of cisplatin (CDDP)-treated patients. Traditional biomarkers including blood urea nitrogen (BUN) and serum creatinine (SCr) are still used for detection CDDP-induced AKI, but these not specific or sensitive. The aim this study was to identify the sensitive against renal between young (3-week-old) old (20-week-old) rats. All animals were intraperitoneally injected once with CDDP (6 mg/kg). After 3 days, all sacrificed serum, urine, tissues collected. Urinary as well histological changes measured. proximal tubular damage apparent from histopathological examination, being more severe 3-week-old rats accompanied by increased number TUNEL-positive apoptotic cells. This associated elevated urinary molecule-1 (KIM-1), glutathione-S-transferase alpha (GST-α), vascular endothelial growth factor (VEGF), tissue inhibitor metalloproteinases-1 (TIMP-1). In contrast, levels neutrophil gelatinase-associated lipocalin (NGAL) osteopontin significantly 20-week-old after treatment. These results indicate that use age-specific is necessary diagnosis AKI. Especially, KIM-1, GST-α, TIMP-1, VEGF may help early patients

参考文章(38)
Prasad Devarajan, Marie H. Hanigan, Cisplatin nephrotoxicity: molecular mechanisms. Cancer therapy. ,vol. 1, pp. 47- 61 ,(2003)
Fumie Shiraishi, Lisa M. Curtis, Leigh Truong, Kenneth Poss, Gary A. Visner, Kirsten Madsen, Harry S. Nick, Anupam Agarwal, Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. American Journal of Physiology-renal Physiology. ,vol. 278, ,(2000) , 10.1152/AJPRENAL.2000.278.5.F726
Won K. Han, Veronique Bailly, Rekha Abichandani, Ravi Thadhani, Joseph V. Bonventre, Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury Kidney International. ,vol. 62, pp. 237- 244 ,(2002) , 10.1046/J.1523-1755.2002.00433.X
B.H. Ali, M. Al-Moundhri, M. Tageldin, I.S. Al Husseini, Mohmed A. Mansour, A. Nemmar, M.O. Tanira, Ontogenic aspects of cisplatin-induced nephrotoxicity in rats. Food and Chemical Toxicology. ,vol. 46, pp. 3355- 3359 ,(2008) , 10.1016/J.FCT.2008.07.030
J. D. Stewart, H. M. Bolt, Cisplatin-induced nephrotoxicity Archives of Toxicology. ,vol. 86, pp. 1155- 1156 ,(2012) , 10.1007/S00204-012-0887-2
Dong Wang, Stephen J. Lippard, Cellular processing of platinum anticancer drugs. Nature Reviews Drug Discovery. ,vol. 4, pp. 307- 320 ,(2005) , 10.1038/NRD1691
H T M Jongejan, A P Provoost, E D Wolff, J C Molenaar, Nephrotoxicity of cis-platin comparing young and adult rats. Pediatric Research. ,vol. 20, pp. 9- 14 ,(1986) , 10.1203/00006450-198601000-00003
Tobias Christian Fuchs, Philip Hewitt, Biomarkers for Drug-Induced Renal Damage and Nephrotoxicity—An Overview for Applied Toxicology Aaps Journal. ,vol. 13, pp. 615- 631 ,(2011) , 10.1208/S12248-011-9301-X
E M Faustman, S M Silbernagel, R A Fenske, T M Burbacher, R A Ponce, Mechanisms underlying Children's susceptibility to environmental toxicants. Environmental Health Perspectives. ,vol. 108, pp. 13- 21 ,(2000) , 10.1289/EHP.00108S113
Marshall P. Goren, Reba K. Wright, Marc E. Horowitz, Cumulative renal tubular damage associated with cisplatin nephrotoxicity. Cancer Chemotherapy and Pharmacology. ,vol. 18, pp. 69- 73 ,(1986) , 10.1007/BF00253068